CEPID 2001-2013
CEPID 2013-2024

About the Center for Cell-Based Therapy (CTC)

WEBSITE: http://ctcusp.org

Principal Investigator: Dimas Tadeu Covas

Education and Knowledge Diffusion Coordinator: Marisa Ramos Barbieri

Technology Transfer Coordinator: Flávio Vieira Meirelles

University of São Paulo (USP)
Fundação Hemocentro de Ribeirão Preto
Rua Tenente Catão Roxo, 2.501
14051-140 - Ribeirão Preto, SP - Brasil
55 16 2101 9300/9309

Federal University of São Carlos (UFSCAR)
Hemotherapy Center of Ribeirão Preto (FUNDHERP)
King's College, United Kingdom
Leiden University, Netherlands
Northwestern University, USA
Paris University, France
São Paulo State University (UNESP)
University of California, USA
University of Feinberg, USA
University of Guelph, Canada
University of Montreal, Canada
University of Munchen, Germany
University of Oxford, United Kingdom
University of Southern California, USA


Research projects supported in this Center at FAPESP's Virtual Library

Center leaflet (pdf):

Center for Cell-Based Therapy

Genetic profile of tumor can indicate best treatment for brain cancer patients

A study conducted by researchers at the Center for Cell-Based Therapy identified a genetic signature that can be used to predict whether patients should be submitted to radiation therapy.

Two anti-inflammatory compounds shown to be capable of accelerating recovery from COVID-19

Monoclonal antibody tested by RIDC CTC researchers and experimental drug given to patients in Italy by University of Pennsylvania research group promoted rapid improvement of respiratory function in patients hospitalized in severe condition.

Non-hereditary mutation acts as natural gene therapy in patient with rare disease

Scientists at the Center for Cell-Based Therapy identified a non-inherited mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other clinical manifestations.

Only 1.2% of population of largest city in north of São Paulo State have been infected by SARS-CoV-2

Estimate is based on testing of 700 inhabitants of Ribeirão Preto in early May. Another round of testing will be conducted in June. The study is carried out by the University of São Paulo in partnership with the city’s health department

Brazilian researchers test treatment with antibodies from patients who have recovered from COVID-19

Scientists affiliated with the FAPESP-funded Center for Cell-Based Therapy have collected plasma from donors and are conducting a trial to check the safety and effectiveness of passive immunization.

Researchers report discoveries regarding a molecule with the potential to treat ovarian cancer

The FAPESP-funded Center for Cell-Based Therapy explored the action mechanism of a microRNA that reduces tumor size and blocks metastasis when overexpressed.

Patient’s own cells are used in innovative treatment for cancer

Patient with advanced refractory lymphoma was treated in Brazil by researchers at a center funded by FAPESP. The technique known as CAR T-cell therapy was used for first time ever in Latin America.

New mechanisms that regulate pluripotency in embryonic stem cells are discovered

A study by researchers at the Center for Cell-Based Therapy identified microRNAs involved in pluripotency maintenance and cell differentiation. The discovery paves the way to the development of drugs capable of making ESCs regress to the earliest stage of development.